Bone marrow collection with Perfusion method

Bone marrow collection with Perfusion method - Bone marrow collection with Perfusion method

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009020

Enrollment

Registered

2012-10-01

Start date

2012-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HLA matched related donor

Interventions

To evaluate feasibility of bone marrow collection with perfusion method

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Written informed consent 2) Availability of HLA-matched donor. 3) Performance status :0 or 1(ECOG) 4) Sufficient organ function Serum total billirubin is needed to be less than 2.0mg/dl Serum creatinine level is needed to be less than 2.0mg/dl PaO2>=60mmHg or SpO2>=90%(room air) Normal ECG and Ejection fraction>=50% 5) Patients who are considered as appropriate after examination

Exclusion criteria

Exclusion criteria: Positivity of HBs Ag, HIV Ab (not exclusion of HCV Ab positive) Patient with active infection Bone marrow show fibrosis Patients who are considered as inappropriate with other reasons

Design outcomes

Primary

Measure	Time frame
Donor: To evaluate feasibility of perfusion method	—

Secondary

Measure	Time frame
Donor :operation time, anesthesia time numbers of puncture site, volume of blood transfusion, number of bone marrow nuclear cell, number of CD3-positive cells, number of CD34-positive cells, contamination of red blood cells,CFU-F	—

Countries

Japan

Contacts

Public ContactKazuyoshi Ishii

Kansai Medical University Hirakata Hospital Clinical Department of Hematology- Oncology

ishiikaz@hirakata.kmu.ac.jp072-804-0101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026